The public markets appear to be in recovery mode from 2016’s light class of initial public offerings. With 11 companies listing this week, marking a two-year record, this year’s 81-member cohort is on pace to eclipse 2016’s batch of 119, the smallest group since 2009.
Here is a preview of the offerings set between June 27 and June 30.
11 IPOs This Week
Avenue Therapeutics, Inc. (ATXI) will issue 5 million shares between $5 and $7 Tuesday on the Nasdaq. A Fortress Biotech Inc FBIO subsidiary, the pharmaceutical acquires, develops and commercializes products for in-hospital use, such as its post-operative palliative.Esquire Financial Holdings, Inc. (ESQ) will issue more than 2.36 shares between $14 and $16 Tuesday on the Nasdaq. The business-focused commercial bank has two locations in New York and Florida.Mersana Therapeutics, Inc. (MRSN) will issue 5 million shares between $14 and $16 Wednesday on the Nasdaq. The clinical-stage pharmaceutical specializes in immunoconjugate therapies targeting diverse forms of cancer.TPG Pace Holdings Corp. (TPGHU) will issue 40 million shares at $10 Wednesday on the New York Stock Exchange. Formed by TPG, the firm acquires relevant businesses and stocks across industries, from health care and digital media to real estate and energy.Aileron Therapeutics Inc (ALRN) will issue 3.75 million shares between $15 and $17 Thursday on the Nasdaq. The biopharmaceutical firm targets suppressor proteins to halt tumor progression.Blue Apron Holdings, Inc. (APRN) will issue 30 million shares between $15 and $17 Thursday on the NYSE. The meal-kit service delivers pre-portioned ingredients directly to the consumer.Byline Bancorp, Inc. (BY) will issue 5.7 million shares between $19 and $21 Thursday on the NYSE. The century-old commercial bank has more than 50 branches in the Chicago and Milwaukee areas with offices nationwide.
Dova Pharmaceuticals, Inc.(DOVA) will issue more than 4.06 million shares between $15 and $17 Thursday on the Nasdaq. As a clinical-stage company, Dova acquires, develops and commercializes drug candidates for rare diseases.
Tintri, Inc. (TNTR) will issue 8.7 million shares between $10.50 and $12.50 Thursday on the Nasdaq. With cloud management software, all-flash storage systems and diverse web services, Tintri serves clients ranging from Chevron Corporation CVX and Sony Corp (ADR) SNE to Toyota Motor Corp (ADR) TM and Comcast Corporation CMCSA.
Akcea Therapeutics, Inc. (AKCA) will issue 9.62 million shares between $12 and $14 Friday on the Nasdaq. The subsidiary of Ionis Pharmaceuticals Inc IONS emphasizes RNA-targeted treatments for lipid-based cardiometabolic disorders.
ShiftPixy, Inc. (PIXY) will issue 2 million shares between $6 and $8 Friday on the Nasdaq. The recruiting and scheduling platform connects employers with immediately available shift workers.
Related Links:
3 Important Dates For all IPOs, Explained
How The Biggest Tech IPOs Traded On Their First Day
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
